896-55084-37780 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-07-16
Dose 1 — Pfizer-BioNTech
2022-08-21
Dose 2 — Pfizer-BioNTech
2022-11-04
Registered in v-safe
2022-11-04
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2022-11-04
Health check-in — day 0, dose 3, under 3
Feeling: Fair · Site: Pain · Sleepiness, Irritability/crying

Under 3 check-in
2022-11-05
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Fair · Site: Pain · Sleepiness, Irritability/crying

Under 3 check-in
2022-11-06
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Good · Site: Pain · None

Under 3 check-in
2022-11-07
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Good · Site: Pain · None

Under 3 check-in
2022-11-08
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Good · None

Under 3 check-in
2022-11-09
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Good · None

Under 3 check-in
2022-11-10
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Good · None

Under 3 check-in
2022-11-11
Health check-in — day 7, dose 3, under 3
Feeling: Good · None

Under 3 check-in
2022-11-18
Health check-in — day 14, dose 3, under 3
Feeling: Good

Under 3 check-in
2022-11-25
Survey response — day 21, dose 3, under 3
MedDRA: Nasopharyngitis, Viral infection — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Virus infection/cold

MedDRA releases: 2024-11 · check-in free text available
2022-11-25
Report sent to call center — day 21, dose 3, under 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-11-28
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-12-04
Survey response — day 28, dose 3, under 3
MedDRA: Nasopharyngitis — Feeling: Fair

Free text: Cold symptoms

MedDRA releases: 2024-11 · check-in free text available
2022-12-09
Survey response — day 35, dose 3, under 3
MedDRA: Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair

Free text: Cold symptoms, sore throat and congestion

MedDRA releases: 2024-11 · check-in free text available
2023-02-03
Health check-in — 3 months, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-05-05
Health check-in — 6 months, dose 3, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-07-16	Pfizer-BioNTech	No
2	2022-08-21	Pfizer-BioNTech	No
3	2022-11-04	Pfizer-BioNTech	Flu

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 12 (Under 3) — day 21, dose 3, under 3

2022-11-25

Symptoms: Virus infection/cold

Release 12 (Under 3) — day 28, dose 3, under 3

2022-12-04

Symptoms: Cold symptoms

Release 12 (Under 3) — day 35, dose 3, under 3

2022-12-09

Symptoms: Cold symptoms, sore throat and congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Nasopharyngitis	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Viral infection	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release